China SXT Pharmaceuticals
SXTC
SXTC
3 hedge funds and large institutions have $291K invested in China SXT Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
1
Virtu Financial
New York
|
$182K |
| 2 |
SIM
2
Spark Investment Management
New York
|
$94K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$15K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $182K | 26,714 | +26,714 | New |
|
|
SIM
2
Spark Investment Management
New York
| $94K | 13,800 | +13,800 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $15K | 2,211 | +2,211 | New |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|